An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
Abroad (travel likely)RecruitingPHASE3
Conditions
Hidradenitis Suppurativa
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Novartis Investigative Site, Caba, Buenos Aires, Argentina
Novartis Investigative Site, CABA, Argentina
Novartis Investigative Site, Sydney, New South Wales, Australia
Novartis Investigative Site, Melbourne, Victoria, Australia